Developing tools/algorithms for objective evaluation of sleep health
What are the best tools/algorithms for robust and objective evaluations of sleep health biomarkers?
What are the best tools/algorithms for robust and objective evaluations of sleep health biomarkers?
Would improving sleep and circadian rhythms in the critical care setting result in improved patient outcomes (e.g., reduce severity of infection, duration of intubation, length of hospital stay)?
Are dietary fruits and vegetables, particularly leafy greens, protective against cardiovascular disease due to their ability to increase bioavailability of nitric oxide?
Goal 3: Advance Translational Research
What are the most effective trans-disciplinary and multi-level strategies for accelerating psychosocial care with sickle cell disease and how psychosocial factors impact families?
How can we best integrate primary and specialty palliative care into the care of patients with serious heart, lung, and blood diseases?
What are the best, evidence-based models to facilitate holistic care across the lifespan for individuals living with sickle cell?
Goal 3: Advance Translational Research
How can we ensure that patients with serious heart, lung, or blood diseases fully understand their prognosis, treatment options, and the risks and benefits of those options and help them make decisions that fully incorporate their own personal values, goals, and treatment preferneces?
Goal 3: Advance Translational Research
What factors are associated with high quality care coordination in patients with COPD?
Goal 3: Advance Translational Research
Does palliative care and/or hospice care as practiced across communities improve end-of-life care for COPD – specifically, does it reduce the burden of symptoms, improve HRQoL and satisfaction, reduce utilization in last 6 months of life (i.e. hospital visits, cost, invasive ventilation use, etc), improve the end-of-life experience, and increase the concordance of place of death to expressed patient preferences?
Goal 3: Advance Translational Research
What measures other than PFT data can be used to predict risk of 1) COPD exacerbations (e.g., hospitalization, urgent care visit, or ED visit for COPD exacerbation) or 2) relapse (e.g., re-hospitalization, urgent care visit, or ED visit) following hospital discharge after treatment of COPD exacerbations?
Goal 3: Advance Translational Research
How can guideline recommendations be implemented into community practice in a way that is feasible, usable, relevant, and cost-effective? (examples are use of care management, translation of chronic care model, and EMR based tools)
Goal 3: Advance Translational Research
What can be done in primary care settings to increase appropriate provider assessment of the need for oxygen and prescription of LTOT?
Goal 3: Advance Translational Research
How should providers coordinate management strategies and treatment goals in patients with COPD and other co-existing chronic diseases?
Goal 3: Advance Translational Research
Sickle cell treatment centers are located throughout the United States, primarily in urban areas, and play an invaluable role. However, there is a critical need to identify and educate primary care providers who can provide routine and preventive care, but will also know when to consult with/refer to hematologists and other appropriate providers when necessary.
Goal 3: Advance Translational Research